Analysts have updated their ratings on Agilent Technologies (NYSE:A), with 7 analysts offering diverse perspectives in the last three months. The average 12-month price target is $137.57, with recent adjustments reflecting a positive sentiment shift. Agilent, a life sciences and diagnostics firm, has a strong market presence but has seen a revenue decline of -8.71% as of October 31, 2023. Despite this, the company maintains a high net margin of 28.14% and an ROE of 8.33%, with a healthy debt-to-equity ratio of 0.47.